Synergistic in vitro activity between aztreonam and amoxicillin–clavulanate against Enterobacteriaceae-producing class B and/or class D carbapenemases with or without extended-spectrum β-lactamases-Reference-Cited by-同舟云学术

Synergistic in vitro activity between aztreonam and amoxicillin–clavulanate against Enterobacteriaceae-producing class B and/or class D carbapenemases with or without extended-spectrum β-lactamases

Published:2019-09-01 Issue:9 Volume:68 Page:1292-1298
ISSN:0022-2615
Container-title:Journal of Medical Microbiology
language:en
Short-container-title:

Author:

Ract Pauline¹²^ORCID,Compain Fabrice¹²,Robin Frédéric³⁴,Decre Dominique⁵⁶,Gallah Salah⁶^ORCID,Podglajen Isabelle²¹^ORCID

Affiliation:

1. Université Paris Descartes, Sorbonne Paris Cité, Paris 75006, France

2. Service de Microbiologie, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France

3. Centre National de Référence de la résistance aux Antibiotiques (ESBL/cephalosporinases), CHU Clermont-Ferrand, France

4. Laboratoire de Bactériologie Clinique, CHU Clermont-Ferrand, France

5. Université Pierre et Marie Curie, Paris, France

6. Département de Bactériologie, Assistance Publique-Hôpitaux de Paris, GH Est Parisien, Paris, France

Publisher

Microbiology Society

Subject

Microbiology (medical),General Medicine,Microbiology

Reference20 articles.

1. Treating infections caused by carbapenemase-producing Enterobacteriaceae

2. Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae

3. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study

4. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study

5. Epidemiology of Carbapenemase-Producing Enterobacteriaceae andAcinetobacter baumanniiin Mediterranean Countries

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aztreonam Combinations with Avibactam, Relebactam, and Vaborbactam as Treatment for New Delhi Metallo-β-Lactamase-Producing Enterobacterales Infections—In Vitro Susceptibility Testing;Pharmaceuticals;2024-03-17

2. The burden of antibiotic resistance of the main microorganisms causing infections in humans – review of the literature;Journal of Medicine and Life;2024-03

3. Comparative metabolomics reveal key pathways associated with the synergistic activities of aztreonam and clavulanate combination against multidrug-resistant Escherichia coli;mSystems;2023-12-21

4. Pharmacokinetic/Pharmacodynamic Evaluation of Aztreonam/Amoxicillin/Clavulanate Combination against New Delhi Metallo-β-Lactamase and Serine-β-Lactamase Co-Producing Escherichia coli and Klebsiella pneumoniae;Pharmaceutics;2023-01-11

5. Epidemiology, Mechanisms of Resistance and Treatment Algorithm for Infections Due to Carbapenem-Resistant Gram-Negative Bacteria: An Expert Panel Opinion;Antibiotics;2022-09-17